LifeTech Scientific Corporation
Research LifeTech Scientific Corporation (1302.HK) on Bullrun: market cap HKD 6.23B, P/E 141.5. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1302.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryMedical Devices
- CurrencyHKD
- Market capHKD 6.23B
- P/E141.5
- Financial periodFY2025
- RevenueCNY 1.37B
- Revenue growth5.1%
- Net incomeCNY 147.83M
- Free cash flowCNY 399.03M
- Gross margin74.4%
Valuation Snapshot
latest market cap is HKD 6.23B; P/E is 141.5.
Peer valuation comparison
Latest P/E is 141.5x versus a Healthcare sector median of 21.74x (550.7% above).
Latest P/E is 141.5x versus a China median of 16.26x (770.1% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 1.37B | CNY 147.83M | CNY 399.03M | 74.4% | 0.03 | CNY 719.32M | CNY 8.04M | CNY 3.51B |
| FY2024 | CNY 1.30B | CNY 222.39M | CNY 38.46M | 75.3% | 0.05 | CNY 665.76M | CNY 4.98M | CNY 3.49B |
| FY2023 | CNY 1.27B | CNY 263.24M | CNY 125.36M | 78.6% | 0.06 | CNY 979.31M | CNY 9.30M | CNY 3.37B |
| FY2022 | CNY 1.10B | CNY 325.34M | CNY 52.85M | 79.6% | 0.07 | CNY 833.79M | CNY 9.67M | CNY 2.90B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-17 | HKD 6.23B | 141.5 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 HKD.
About LifeTech Scientific Corporation
LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. It is also involved in biomedical research and development;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is LifeTech Scientific Corporation's market cap?
LifeTech Scientific Corporation's market capitalization is HKD 6.23B.
What is LifeTech Scientific Corporation's P/E ratio?
LifeTech Scientific Corporation's price-to-earnings (P/E) ratio is 141.5.
What does LifeTech Scientific Corporation do?
LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments.